Ensol Biosciences (XKRX:140610) EV-to-Revenue : 384.87 (As of Jun. 23, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ensol Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ensol Biosciences's enterprise value is ₩67,946.3 Mil. Ensol Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩176.5 Mil. Therefore, Ensol Biosciences's EV-to-Revenue for today is 384.87.

The historical rank and industry rank for Ensol Biosciences's EV-to-Revenue or its related term are showing as below:

XKRX:140610' s EV-to-Revenue Range Over the Past 10 Years
Min: 67.04 Med: 236.48 Max: 474.29
Current: 384.87

During the past 10 years, the highest EV-to-Revenue of Ensol Biosciences was 474.29. The lowest was 67.04. And the median was 236.48.

XKRX:140610's EV-to-Revenue is ranked worse than
91.78% of 1034 companies
in the Biotechnology industry
Industry Median: 7.69 vs XKRX:140610: 384.87

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), Ensol Biosciences's stock price is ₩5900.00. Ensol Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩16.46. Therefore, Ensol Biosciences's PS Ratio for today is 358.36.

Ensol Biosciences EV-to-Revenue Historical Data

The historical data trend for Ensol Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensol Biosciences EV-to-Revenue Chart

Ensol Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

127.81

214.67

385.13

90.68

404.49

Ensol Biosciences Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue	Get a 7-Day Free Trial					127.81	214.67	385.13	90.68	404.49

Competitive Comparison of Ensol Biosciences's EV-to-Revenue

For the Biotechnology subindustry, Ensol Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ensol Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ensol Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ensol Biosciences's EV-to-Revenue falls into.

Ensol Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ensol Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	67946.303	/	176.545
	=	384.87

Ensol Biosciences's current Enterprise Value is ₩67,946.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ensol Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩176.5 Mil.

Ensol Biosciences (XKRX:140610) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ensol Biosciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5900.00	/	16.464
	=	358.36

Ensol Biosciences's share price for today is ₩5900.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩16.46.

Ensol Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ensol Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Ensol Biosciences (XKRX:140610) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ensol Biosciences Inc (XKRX:140610) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

51, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34036

Website

http://www.ensolbio.co.kr

Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.

Ensol Biosciences (XKRX:140610) Headlines

No Headlines